USA. … Osteoporosis is a silent disease, often displaying no signs or symptoms until a fracture occurs, leaving a majority of patients undiagnosed and undertreated. Amgen Science Some of the greatest advances in science are unfolding now inside Amgen. He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. We are proud of our deep and diverse pipeline of leading-edge, first-in-class therapeutic approaches aimed to dramatically improve outcomes. However, if you like to, you can change your cookie settings at any time. Today Amgen makes more than a dozen medicines across multiple therapeutic areas — and its highly sophisticated global manufacturing network has helped it reach millions of patients with its medicines. Reimbursement Support Services and Financial Assistance Programs. At Amgen, we are developing innovative medicines for novel targets in difficult-to-treat cancers. A … Amgen’s Commitment to Patients. The treatment of millions of seriously ill patients worldwide depends on the safe and reliable production of biologic medicines, which are administered by injection or intravenously. “Amgen’s pipeline has never been as broad in terms of targets and diseases that we’re targeting, spanning from small molecules to BiTE molecules and beyond.” Share This Story. In 2007, he was appointed vice president, General Manager in France. The firm is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, later stage, and emerging companies. degree in biochemistry from Middlebury College and M.D. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. YOU ARE NOW LEAVING THIS WEBSITE. Founded 2004. If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org. Supplier Sustainability . In 2007, he was appointed vice president, General Manager in France. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. Join to Connect. We are proud of what we have accomplished—and eager to do more. Wilt u deze Externe Website bezoeken en Amgen.nl verlaten? Expertise in oncology and inflammatory chronic diseases. © 1996-2021 Amgen Inc. All Rights Reserved. Therapeutic Areas | Amgen. Diversity and Inclusion. Amgen Pipeline ; Introduction in Biotechnology ; BiTE ® Immuno-Oncology Platform; Clinical Research; Amgen Biosimilars ; Products. Sunday 18 March 2018 12.30–14.00 Lisbon Congress Center Lisbon, Portugal. Access to Medicine. from New York Medical College. Amgen’s business development team brings together deep scientific, financial, deal, partnership, and integration expertise—along with an ability to bring the right people inside Amgen to the right conversations. Learn More . Considering minimal residual disease and HSCT in adult ALL: role of innovative therapeutic modalities Amgen-sponsored satellite symposium at EBMT 2018. Amgen seeks licensing opportunities that match our strategy and expand our capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, and discovery research and technology. If you continue without changing your settings, this will indicate your consent to receive all cookies on the Amgen website. About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. Savings generated across multiple therapeutic areas Environment. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products. PRODUCTS We go well beyond the development of innovative medicines and preventive therapies. Amgen’s Commitment to Patients. Deep Experience Worldwide Biologics Leader Therapeutic Area Heritage Expertise . LEARN MORE Towards a brave new world – Evolution and revolution in the treatment of multiple myeloma Amgen-sponsored satellite symposium at EBMT 2018. Do you want to link to this External Website and leave Amgen.nl? I ACCEPT. Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. 2017 Responsibility Highlights Report. If you have a question on one of our products please select the relevant therapeutic area: Diabetes Endocrine Musculoskeletal Neuroscience Oncology Urology Dermatology & Rheumatology. Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently, Rheumatic diseases such as rheumatoid arthritis, Bowel disorders such as Crohn's disease and Colitis Ulcerosa. Amgen heeft een aantal websites gemaakt om u beter tot dienst te zijn bij specifieke vragen. Our medicines typically address diseases Contact Lilly. Amgen’s scientific success has been rooted in a unique “triple threat” capability that includes world-class human genetics, a deep understanding of disease biology, and the molecular engineering expertise needed to design the right drug for the right target. Welcome to Amgen Education (Europe) Providing European healthcare professionals with information and access to exclusive downloads from Amgen educational events. Amgen Education - Therapeutic Area Page. Stay Connected With Amgen. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A … Amgen has been the recipient of numerous awards and accolades over the years, ranging from recognition of our pioneering science and innovation, philanthropy and corporate social responsibility to our commitment to being a great place to work. It appears that Amgen's key focus at least for product development has narrowed to three core therapeutic areas – oncology, cardiovascular disease … Core therapeutic areas Platforms for growth Luke Miels, Executive Vice President, Global Portfolio & Product Strategy and Corporate Affairs . With the advances in human genetics, Amgen continues to shed new light on the molecular roots of disease. Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Environment. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a … Business Development plays a critical role in the execution of Amgen’s growth strategy. He completed his residency training in Internal Medicine at Dartmouth-Hitchcock Medical Center and his fellowship training in Hematology and Oncology at The University of Chicago Hospitals. … Previously, Gilles was vice president, Global Marketing Therapeutic Area Head for cardiovascular and neurosciences. We do this in a number of ways, especially through acquisitions and licensing agreements that include investigational medicines in specific therapeutic areas as well as discovery research capabilities and delivery system technologies. Our medicines typically address diseases for which there are limited treatment options, or they are medicines that provide a viable option to what is otherwise available. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Diversity and Inclusion. Amgen Netherlands takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. Black and white images (left to right) (top to bottom): A row of roller bottles in Building 6. Cardiology. As the third product launch in Amgen’s oncology biosimilar portfolio, this milestone reflects the company’s commitment to providing high-quality biosimilars and delivering cost savings for patients, physicians, payers, hospitals and health systems over the long term. Join to Connect. Amgen Nederland draagt geen verantwoordelijkheid voor, en oefent geen controle uit, over de organisaties, meningen or juistheid van de informatie van deze server of website. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. At Amgen, business development focuses on bringing external innovation into the corporation. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. Amgen Foundation. degree in biochemistry from Middlebury College and M.D. Global CMC Therapeutic Area Head, General Medicine at Amgen Greater Los Angeles Area 500+ connections. CARDIOVASCULAR; ONCOLOGY/HAEMATOLOGY; NEPHROLOGY; BONE; BIOSIMILARS; UPCOMING (0) COMPLETED (4) OTHER (0) ALL (4) Kidney Week 2019: expert insights on CKD-MBD and beyond On … Diversity and Inclusion. Amgen is active in around 100 countries worldwide. Osteoporotic fractures create a significant healthcare burden, and represent a significant unmet medical need. from New York Medical College. Amgen Foundation. 2017 Responsibility Highlights Report. Amgen therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases. We focus on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience.